73 material Form 8-K filings that 66 companies we cover made with the SEC in January 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
W. R. Berkley reported fourth-quarter 2023 net income to common stockholders of $397.3 million, or $1.47 per diluted share, up from $382.2 million, or $1.37 per diluted share, a year earlier. The company cited record pre-tax underwriting income of $315.9 million and a 23.6% return on equity, and said book value per share grew 11.6% before dividends and buybacks. For full-year 2023, diluted EPS rose to $5.05 from $4.94, while net income was roughly flat at $1.38 billion.
Q4 2023 net income to common stockholders: $397.3 million, versus $382.2 million in Q4 2022
Q4 2023 diluted EPS: $1.47, versus $1.37; full-year diluted EPS: $5.05, versus $4.94
Record Q4 pre-tax underwriting income of $315.9 million, up 8.2%
Book value per share was $29.06 at December 31, 2023, versus $25.51 a year earlier
OFG Bancorp reported fourth-quarter 2023 results, with diluted earnings per share of $0.98 compared with $0.95 in the prior quarter and $0.97 a year earlier. Total core revenues rose to $175.6 million from $172.2 million in 3Q23 and $168.3 million in 4Q22, and full-year 2023 diluted EPS was $3.83 versus $3.44 in 2022. The filing contains results only and gives no guidance for future periods.
4Q23 diluted EPS $0.98 vs. $0.95 in 3Q23 and $0.97 in 4Q22
4Q23 total core revenues $175.6 million vs. $172.2 million in 3Q23
Full-year 2023 diluted EPS $3.83 vs. $3.44 in 2022; total core revenues $682.7 million vs. $607.8 million
4Q23 included a $6.3 million pre-tax gain on sale of non-performing loans and $3.2 million in severance and lease cancellation costs
Elevance Health reported fourth-quarter and full-year 2023 results in a press release furnished under Item 2.02 of this 8-K. Quarterly operating revenue rose 7.0% to $42.5 billion and GAAP diluted EPS rose 1.1% to $3.63, while the company set a full-year 2024 GAAP diluted EPS outlook of greater than $34.29, compared with $25.22 for 2023, and raised its quarterly dividend 10.1% to $1.63 per share.
4Q 2023 operating revenue $42.5 billion, up 7.0%; GAAP diluted EPS $3.63, up 1.1%; adjusted diluted EPS $5.62, up 15.2%
FY 2024 GAAP diluted EPS outlook greater than $34.29; adjusted diluted EPS outlook greater than $37.10, versus FY 2023 GAAP diluted EPS of $25.22
Quarterly dividend increased 10.1% to $1.63 per share
4Q 2023 operating margin was 3.0%, down from 3.2% in 4Q 2022
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.